Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Neuronetics, River Region Psychiatry Announce Exclusive Partnership


Benzinga | Nov 8, 2021 10:03AM EST

Neuronetics, River Region Psychiatry Announce Exclusive Partnership

Neuronetics, Inc. (NASDAQ:STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, and River Region Psychiatry Associates (RRPA), a leading provider of mental health services in Alabama, Kentucky, Tennessee, and Georgia, announced today a partnership agreement under which Neuronetics will be the exclusive supplier of transcranial magnetic stimulation (TMS) equipment to RRPA and its clinics. The first NeuroStar Advanced Therapy system will launch in the Pelham/Helena, Alabama community, with aspirations to expand into all clinics over the coming year.

"As depression rates increase, this partnership with RRPA will provide more patients access to a non-drug treatment option for depression," said Keith J. Sullivan, President and CEO of Neuronetics. "RRPA's track record of bringing cutting edge treatments to their patient base, coupled with their compassionate approach to patient care, makes this a perfect long-term partnership for us."

Receiving FDA clearance in 2008, NeuroStar(r) Advanced Therapy is a non-invasive, non-drug treatment that uses transcranial magnetic stimulation to target key areas of the brain that are underactive in people with major depressive disorder (MDD). NeuroStar is the leading TMS treatment for depression in adult patients and has been proven to be safe and effective, with over 4 million treatments delivered to over 110,000 patients to-date. Patients treated with NeuroStar achieved a high response rate of 83% and a remission rate of 62% (Sackeim, et al. 2020).

"Our number one priority is providing care and support to our patients, which means offering a variety of proven treatments, including TMS," said Dr. Shankar Yalamanchili, Founder of River Region Psychiatry Associates. "While we looked at other TMS options, NeuroStar was the obvious first choice because of the commitment they have to the success of patients and providers that are offering NeuroStar."

To learn more about NeuroStar(r) Advanced Therapy, visit www.neurostar.com. To learn more about River Region Psychiatry Associates, visit www.rrpa.us.






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC